These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26415219)

  • 1. Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
    Brighenti E; Treré D; Derenzini M
    Oncotarget; 2015 Nov; 6(36):38617-27. PubMed ID: 26415219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.
    Scala F; Brighenti E; Govoni M; Imbrogno E; Fornari F; Treré D; Montanaro L; Derenzini M
    Oncogene; 2016 Feb; 35(8):977-89. PubMed ID: 25961931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics.
    Catez F; Dalla Venezia N; Marcel V; Zorbas C; Lafontaine DLJ; Diaz JJ
    Biochem Pharmacol; 2019 Jan; 159():74-81. PubMed ID: 30468711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.
    Chan JC; Hannan KM; Riddell K; Ng PY; Peck A; Lee RS; Hung S; Astle MV; Bywater M; Wall M; Poortinga G; Jastrzebski K; Sheppard KE; Hemmings BA; Hall MN; Johnstone RW; McArthur GA; Hannan RD; Pearson RB
    Sci Signal; 2011 Aug; 4(188):ra56. PubMed ID: 21878679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.
    Montanaro L; Mazzini G; Barbieri S; Vici M; Nardi-Pantoli A; Govoni M; Donati G; Treré D; Derenzini M
    Cell Prolif; 2007 Aug; 40(4):532-49. PubMed ID: 17635520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis.
    Drygin D; Siddiqui-Jain A; O'Brien S; Schwaebe M; Lin A; Bliesath J; Ho CB; Proffitt C; Trent K; Whitten JP; Lim JK; Von Hoff D; Anderes K; Rice WG
    Cancer Res; 2009 Oct; 69(19):7653-61. PubMed ID: 19738048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ribosome Biogenesis-Cancer Connection.
    Penzo M; Montanaro L; Treré D; Derenzini M
    Cells; 2019 Jan; 8(1):. PubMed ID: 30650663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and ribosome biogenesis stress: the essentials.
    Golomb L; Volarevic S; Oren M
    FEBS Lett; 2014 Aug; 588(16):2571-9. PubMed ID: 24747423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosome biogenesis and cancer.
    Derenzini M; Montanaro L; Trerè D
    Acta Histochem; 2017 Apr; 119(3):190-197. PubMed ID: 28168996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.
    Penzo M; Casoli L; Pollutri D; Sicuro L; Ceccarelli C; Santini D; Taffurelli M; Govoni M; Brina D; Trerè D; Montanaro L
    Int J Cancer; 2015 Mar; 136(5):E272-81. PubMed ID: 25273595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance.
    El Hassouni B; Sarkisjan D; Vos JC; Giovannetti E; Peters GJ
    Curr Med Chem; 2019; 26(33):6020-6032. PubMed ID: 30501594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation.
    Donati G; Brighenti E; Vici M; Mazzini G; Treré D; Montanaro L; Derenzini M
    J Cell Sci; 2011 Sep; 124(Pt 17):3017-28. PubMed ID: 21878508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosome biogenesis and control of cell proliferation: p53 is not alone.
    Donati G; Montanaro L; Derenzini M
    Cancer Res; 2012 Apr; 72(7):1602-7. PubMed ID: 22282659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth control and ribosomopathies.
    Teng T; Thomas G; Mercer CA
    Curr Opin Genet Dev; 2013 Feb; 23(1):63-71. PubMed ID: 23490481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
    Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
    Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
    Bursac S; Brdovcak MC; Donati G; Volarevic S
    Biochim Biophys Acta; 2014 Jun; 1842(6):817-30. PubMed ID: 24514102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
    Brighenti E; Giannone FA; Fornari F; Onofrillo C; Govoni M; Montanaro L; Treré D; Derenzini M
    Oncotarget; 2016 Sep; 7(39):63226-63241. PubMed ID: 27557515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why.
    Derenzini E; Rossi A; Treré D
    J Hematol Oncol; 2018 May; 11(1):75. PubMed ID: 29855342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies.
    Scull CE; Zhang Y; Tower N; Rasmussen L; Padmalayam I; Hunter R; Zhai L; Bostwick R; Schneider DA
    Biochem J; 2019 Aug; 476(15):2209-2219. PubMed ID: 31341008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosome Biogenesis Alterations in Colorectal Cancer.
    Nait Slimane S; Marcel V; Fenouil T; Catez F; Saurin JC; Bouvet P; Diaz JJ; Mertani HC
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.